The table below shows Inhibrx, Inc.'s cash flow statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
Operating cash flow
-$193.31M
-$115.30M
-$80.32M
-$47.97M
-$32.08M
Capital expenditure
$4.59M
$686.00K
$864.00K
$1.36M
$1.81M
Investing cash flow
-$4.59M
-$686.00K
-$809.00K
-$1.36M
-$1.81M
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
INBX operating cash flow (10-K history)
Inhibrx, Inc. reported operating cash flow of -$193.31M for fiscal year 2023. That is down 67.7% from -$115.30M in fiscal 2022. Over the 5 fiscal years shown, operating cash flow declined from -$32.08M (FY 2019) to -$193.31M. Figures come from the company's audited annual reports as filed with the SEC.